These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2336814)

  • 1. [Changes in fibrinolysis in diabetes mellitus].
    Tóthová E; Mechír J; Suchmanová I; Mudronová B
    Vnitr Lek; 1990 Feb; 36(2):163-9. PubMed ID: 2336814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of oxidative stress and fibrinolysis in diabetes mellitus.
    Skrha J; Hodinár A; Kvasnicka J; Hilgertová J
    Diabet Med; 1996 Sep; 13(9):800-5. PubMed ID: 8891455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolytic measurements in type 2 diabetic patients with acute cerebral infarction.
    Mansfield MW; Catto AJ; Carter AM; Grant PJ
    Diabet Med; 1998 Nov; 15(11):953-7. PubMed ID: 9827850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contact (prekallikrein) and fibrinolytic (plasminogen/antiplasmin value) system in the physiopathology of vascular complications of diabetes].
    Janody D; Droulle C; Adjizian JC; Ostermann G; Poynard JP; Jeunehomme G; Leutenegger M; Potron G
    J Mal Vasc; 1982; 7(3):221-4. PubMed ID: 6815291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic retinopathy and the fibrinolytic system.
    Almér LO; Pandolfi M; Nilsson IM
    Diabetes; 1975 Jun; 24(6):529-34. PubMed ID: 49282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolysis and diabetic retinopathy.
    Almér LA; Pandolfi M
    Diabetes; 1976; 25(2 SUPPL):807-10. PubMed ID: 61139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazone.
    Yener S; Comlekci A; Akinci B; Demir T; Yuksel F; Ozcan MA; Bayraktar F; Yesil S
    Med Princ Pract; 2009; 18(4):266-71. PubMed ID: 19494532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ Fibrinolysis in diabetes mellitus].
    Syrbe G; Jütte A; Wittwer E; Deufrains A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(3):317-28. PubMed ID: 2428706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetes mellitus and fibrinolysis (experience with an in vitro clot lysis test)].
    Udvardy M; Pósán E
    Orv Hetil; 1994 Sep; 135(37):2025-7. PubMed ID: 7936609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic response to venous occlusion compared to physical stress test in young patients with coronary artery disease.
    Nikfardjam M; Graf S; Beckmann R; Hornykewycz S; Koller-Strametz J; Binder BR; Huber K
    Thromb Haemost; 1999 Sep; 82 Suppl 1():80-4. PubMed ID: 10695493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Behavior of some indices of fibrinolysis (fibrinogen, FDP, plasminogen) in mature diabetics].
    Di Cesare E; Quartarone M; Cucinotta D; Coppolino E; Squadrito G
    Minerva Med; 1979 May; 70(22):1597-9. PubMed ID: 450299
    [No Abstract]   [Full Text] [Related]  

  • 13. Fibrinolytic activity in Nigerian diabetics.
    Adediran IA; Ikem RT; Borisade MF
    Postgrad Med J; 2004 Oct; 80(948):610-2. PubMed ID: 15466998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
    Christe M; Fritschi J; Lämmle B; Tran TH; Marbet GA; Berger W; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):138-43. PubMed ID: 6084321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in microcirculation and selected laboratory parameters in the early stages of diabetic microangiopathy].
    Skrha J; Prázný M; Kvasnicka J; Kalvodová B
    Cas Lek Cesk; 2001 Jun; 140(12):370-4. PubMed ID: 11503186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
    Moreno JA; Gálvez MM; Cornudella R; Angós JA; Romero MS; Gutiérrez M
    Sangre (Barc); 1994 Apr; 39(2):111-6. PubMed ID: 8059288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
    Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R
    Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of diabetes regulation on platelet release, fibrinolysis and coagulation tests, before and after stimulation with DDAVP.
    vd Knaap JH; de Boer AC; Pannebakker MA; van Heerde W; den Ottolander GJ
    Thromb Haemost; 1985 Feb; 53(1):118-21. PubMed ID: 3922075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of obesity on endogenous fibrinolytic activity in diabetes mellitus.
    Almér LO
    J Med; 1975; 6(5-6):351-67. PubMed ID: 56414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of hyperlipoproteinemia on blood fibrinolytic activity and thrombocyte aggregation].
    Kostić N; Secen S
    Med Pregl; 2000; 53(3-4):180-3. PubMed ID: 10965685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.